Pulmonary drug delivery refers to a form of administering drugs. Here, the drug gets straight to the lungs and provides a complete and local effect. Pulmonary drug delivery systems offer many benefits. Some of these are minimal side effects, rapid action and less dosage.
The pulmonary drug delivery systems market is fragmented on the basis of applications, product kinds and geographical regions. Applications wise, the market is segmented into asthma, cystic fibrosis and chronic obstructive pulmonary disease.
Based on product kinds, the market is divided into dry powder inhalers, metered dose inhalers and nebulizers. The pulmonary drug delivery systems market is also segmented regional wise into Europe, North America, Asia Pacific and rest of the world.